BB BIOTECH AG

Holdings History for Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR)

Symbol: ESPR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 9,694,064 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

BB Biotech AG ownership in Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share (ESPR)

10 Mar 2025 - BB Biotech AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,694,064 shares of Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share (ESPR). This represents 4.9% ownership of the company. In their previous filing dated 14 Feb 2025, BB BIOTECH AG had reported owning 9,944,064 shares, indicating a decrease of +2.5%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BB Biotech AG	4.9%	-2%	$8,821,598	9,694,064	-250,000	-2.5%	$0.91	13G/A	04 Mar 2025	10 Mar 2025, 11:12
BB Biotech AG	5%		$9,049,098	9,944,064			$0.91	13G/A	31 Dec 2024	14 Feb 2025, 14:37

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2019	3.6%	+0.13%	$141,447,000	3,522,964	+130,000	+3.8%	$40.15	Q1 2019
31 Dec 2018	5%	+0.16%	$156,076,000	3,392,964	+110,000	+3.4%	$46.00	Q4 2018
30 Sep 2018	3.9%	+0.12%	$145,665,000	3,282,964	+100,000	+3.1%	$44.37	Q3 2018
30 Jun 2018	3.6%	+0.87%	$124,740,000	3,182,964	+770,000	+32%	$39.19	Q2 2018
31 Mar 2018	4.8%	+0.1%	$174,530,000	2,412,964	+50,000	+2.1%	$72.33	Q1 2018
31 Dec 2017	4.4%	+0.49%	$155,578,000	2,362,964	+265,000	+13%	$65.84	Q4 2017
30 Sep 2017	2.9%	+0.81%	$105,150,000	2,097,964	+584,422	+39%	$50.12	Q3 2017
30 Jun 2017	2.1%	+0.15%	$70,047,000	1,513,542	+105,000	+7.5%	$46.28	Q2 2017
31 Mar 2017	1.6%	+0.12%	$49,736,000	1,408,542	+100,000	+7.6%	$35.31	Q1 2017
31 Dec 2016	0.61%	0%	$16,383,000	1,308,542	0		$12.52	Q4 2016
30 Sep 2016	0.64%	+0.15%	$18,123,000	1,308,542	+300,000	+30%	$13.85	Q3 2016
30 Jun 2016	0.39%	0%	$9,964,000	1,008,542	0		$9.88	Q2 2016
31 Mar 2016	0.68%	+0.07%	$17,054,000	1,008,542	+100,000	+11%	$16.91	Q1 2016
31 Dec 2015	0.57%	0%	$20,224,000	908,542	0		$22.26	Q4 2015
30 Sep 2015	0.68%	+0.68%	$21,433,000	908,542	+908,542	NEW	$23.59	Q3 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.